Global Bipolar Disorder Therapeutics Market to 2026 - Featuring AbbVie, Astellas Pharma and Gedeon Richter Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bipolar Disorder Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Bipolar Disorder Therapeutics estimated at US$5.6 Billion in the year 2020, is projected to reach a revised size of US$6.8 Billion by 2026, growing at a CAGR of 3.1% over the analysis period.

Antipsychotic Drugs, one of the segments analyzed in the report, is projected to grow at a 3% CAGR to reach US$3.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Anticonvulsants segment is readjusted to a revised 3.9% CAGR for the next 7-year period. This segment currently accounts for a 21.8% share of the global Bipolar Disorder Therapeutics market. Generally prescribed to treat schizophrenia, antipsychotic drugs have a wider relevance in managing bipolar disorders.

In bipolar care, antipsychotic drugs are highly preferred in treating periods of psychosis during mania or severe depression. Anticonvulsant drugs aid in the treatment of bipolar disorder and in managing the mania associated with bipolar disorder. Widely prescribed anticonvulsant drugs for bipolar disorder treatment include carbamazepine (Equetro), divalproex sodium (Depakote), lamotrigine (Lamictal), topiramate (Topamax), and valproic acid (Depakene).

Select Competitors (Total 102 Featured) -

• AbbVie Inc.
• Astellas Pharma Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Gedeon Richter Plc
• GlaxoSmithKline Plc
• H. Lundbeck A/S
• Janssen Pharmaceutica N.V.
• Johnson & Johnson Services, Inc.
• Novartis International AG
• Otsuka America Pharmaceutical, Inc.
• Pfizer Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Validus Pharmaceuticals LLC

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Bipolar Disorder Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Impact of Covid-19 and a Looming Global Recession
• Bipolar Disorder Therapeutics - A Prelude
• Symptoms of Bipolar Disorder
• Mood Episode - A Major Symptom
• Manic Episode Vs Depressive Episode
• Causes of Bipolar Disorder
• Types of Bipolar Disorder
• Co-morbidities of Bipolar Disorder
• Segments
• Antipsychotic Drugs
• Antidepressant Drugs
• Anticonvulsants
• Mood Stabilizers
• Anti-Anxiety Drugs
• Select Drugs for Bipolar Disorder Treatment by Drug Class
• Impact of Covid-19 and a Looming Global Recession
• 2020 Marked as a Year of Disruption & Transformation
• The Never-Ending "Race" Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
• Omicron Spreads Panic Worldwide; Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic
• Short-term Impact of Omicron on Travel
• Steps taken by the Countries to Prevent Transmission of Omicron Variant
• Pharma Firms Aim to Improve Existing Vaccines to Counter Omicron
• With IMF Making an Upward Revision of Global GDP for 2021, Companies Are Bullish About an Economic Comeback Despite a Continuing Pandemic
• A Strong Yet Exceedingly Patchy & Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
• COVID-19 Impact on Bipolar Disorder Therapeutics Market
• Global Market Analysis and Prospects
• Bipolar Disorder Therapeutics Market Set to Witness Rapid Growth
• Regional Market Analysis
• Treatment Analysis
• Anti-Psychotics
• Pipeline Drugs in Phase III for Bipolar Disorder
• Select Anti-Psychotic Drugs
• A Review of Anti-Psychotics
• Indications of Antipsychotics
• An Effective Adjunctive Therapy
• Off-label Uses
• Efficacy - Marred by Lack of Evidence Base
• Types of Antipsychotics
• Side Effects of Antipsychotics
• Symptoms of Antipsychotics Withdrawal
• Anti-Depressants
• Market Overview
• Anti-Depressant Market: Percentage Share Breakdown by Depressive Disorder Type
• Anti-Depressant Treatment
• Select Top Selling Anti-Depressants in 2018
• Select Antidepressant Drugs
• Recent Approvals of Anti-Depressants
• Pipeline Drugs in Phase III for Depressive Disorder
• A Review of Depression
• Types of Depressive Disorders
• Available Treatment
• Working of Antidepressants
• Ranking of Antidepressants in Terms of Efficacy
• Types of Antidepressants
• NMDA Receptor Antagonists
• Acetylcholinesterase Inhibitors
• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
• Tricyclic Antidepressants
• Monoamine Oxidase Inhibitors (MOI)
• Benzodiazepines
• Beta Blockers
• Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Market Gains to Continue Amid Rising Prevalence of Bipolar Disorder
• Awareness Programs Augment Prospects
• Increasing R&D Activities Drive the Global Bipolar Disorder Therapeutics Market
• Technology Advancements Widen Addressable Market
• Social Inclusion of People with Mental Illnesses Augurs Well
• Online Self-Management Tools Improve Treatment Outcomes
• Increasing Product R&D, Approvals & Launches Support Market Expansion
• Side Effects of Bipolar Disorder Drugs

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/83prhl

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900